CLINICAL TRIALS PROFILE FOR ALESSE
✉ Email this page to a colleague
All Clinical Trials for ALESSE
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00315107 ↗ | Estrogen Treatment in Acromegalic Women | Unknown status | Novartis | Phase 2 | 2006-05-01 | Oral estrogens may be an effective adjuvant treatment for control of acromegaly in patients with resistance to somatostatin analogs. |
NCT00315107 ↗ | Estrogen Treatment in Acromegalic Women | Unknown status | Université de Montréal | Phase 2 | 2006-05-01 | Oral estrogens may be an effective adjuvant treatment for control of acromegaly in patients with resistance to somatostatin analogs. |
NCT00481650 ↗ | Observational Trial With Leios/Alesse | Completed | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-05-01 | A prospective, observational study (Anwendungsbeobachtung [AWB]) of the prescribing and administration practices of German gynecologists with Leios® Dragées. | |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ALESSE
Condition Name
Clinical Trial Locations for ALESSE
Trials by Country
Clinical Trial Progress for ALESSE
Clinical Trial Phase
Clinical Trial Sponsors for ALESSE
Sponsor Name